Accellent Inc., the largest provider of fully integrated outsourced manufacturing and engineering services to the medical device industry, announced today that affiliates of Kohlberg Kravis Roberts & Co. (“KKR”) and Bain Capital LLC have completed their acquisition of the company through a transaction valued at $1.27 billion. On October 10, 2005, Accellent announced the signing of a definitive merger agreement with an affiliate of KKR.

“We are very pleased to announce the completion of the acquisition of Accellent,” said Ron Sparks, President and CEO of Accellent. “We look forward to continuing to build upon our strong track record of meeting the needs of our customers and providing them with the highest level of service.”

In connection with the completion of the acquisition, Accellent Corp., a wholly owned subsidiary of Accellent Inc. announced last week that it has accepted for payment and paid for 100% of its outstanding $175,000,000 aggregate principal amount of 10% Senior Subordinated Notes due 2012, pursuant to its previously announced cash tender offer and consent solicitation for the Notes.

KKR is one of the world's oldest and most experienced private equity firms specializing in management buyouts, with offices in New York, Menlo Park, California, London, Paris and Hong Kong. Current KKR investments in the health care sector include: Alliance Imaging; Jazz Pharmaceuticals; and MedCath. Throughout its history, KKR has brought a long-term investment approach to its portfolio companies, focusing on working in partnership with management teams to invest for future competitiveness and growth. Over the past 29 years, KKR has invested in more than 130 transactions with a total value of over US$162 billion.

Bain Capital is a global private investment firm that manages several pools of capital including private equity, high-yield assets, mezzanine capital, venture capital, and public equity with more than $26 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in over 230 companies around the world.